Medical University Graz is a 1600 bed University Hospital located in Graz, Austria with over 6400 employees. In the field of diabetes, the Division for Endocrinology and Metabolism at the Department of Internal Medicine offers extensive outpatient and inpatient services. An affiliated clinical research centre (CRC) is available for pre-clinical and clinical investigations focusing on the development of new research technologies (e.g. single-port artificial pancreas), on the pathophysiology of late complications and on the investigation of new pharmaceutical approaches for the treatment of diabetes mellitus. Within PCDIAB this partner will lead WP 4 (Examination of interactions between subcutaneous glucagon administration and continuous glucose monitoring) and will participate in WP 3 (Home Testing of the Artificial Pancreas) and WP 5 (Glucagon Pharmacology). GRZ’s experience covers the clinical validation of safety and efficacy of pharmaceutical products (e.g., insulin analogues; Ref. 1, 2) and medical devices (e.g., glucose monitoring systems, Ref. 3-5) as well as the development and clinical evaluation of new methods to improve diabetes management, including single-port treatment approaches (Ref. 6, 7). Furthermore, GRZ has coordinated and participated in numerous large consortium EC funded projects.
Werner Regittnig received the Master’s and Ph.D. degrees in Electro- and Biomedical Engineering from the University of Technology Graz, Austria, in 1993 and 1998, respectively. In 1999-2001 he was a Postdoctoral fellow at the Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA and is currently a Senior Scientist at the Medical University of Graz, Austria. His research interests include carbohydrate and lipid metabolism and the integration of insulin delivery and glucose sensing for improved treatment of type 1 diabetes. He is author and co-author of several peer reviewed publications and holds several patents in this field.
Gerd Köhler studied medicine at the Medical University of Graz, Austria and graduated as a medical doctor in 2004. Since then he has been trained for Internal Medicine at the Department of Internal Medicine, Division of Endocrinology and Metabolism at Medical University of Graz. He holds a degree as a Medical Clinical Research Specialist and is a outpatient diabetes expert. At present he holds a position as a consultant in in- and outpatient diabetes treatment. He has been investigator in several inpatient and outpatient clinical phase I to IV studies. His main research interest is outpatient diabetes treatment, the diabetic foot syndrome, tight glycaemic control and the clinical investigation of technologies for out-patient glucose management.
Thomas Pieber is an opinion leader in the field of diabetes. After his Research Fellowships at Heinrich-Heine-University Düsseldorf and University of Texas Southwestern Medical Center, Thomas Pieber became Consultant in Internal Medicine in 1993. From this time on he worked as Assistant Professor, Associate Professor and Consultant in Internal Medicine at University Hospital, Karl-Franzens-University Graz – especially in the Division Diabetes and Metabolism. From 2005 to 2008 he has been the Medical Director of the 1600 bed University Hospital Graz with over 6400 employees. Since July 2008 he is the head of the Division of Endocrinology and Metabolism, Department of Internal Medicine at the Medical University of Graz. Thomas Pieber is head of a working group of 140 people, working in the field of diabetes and metabolism funded through national and international research projects. Thomas Pieber has published around 100 papers in peer reviewed journals, is co-editor of several books and key speaker at international diabetes meetings.